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Making it happen, level 2
F
yson Kasenga (1) describes the detrimental effect
HIV has had on public health in Malawi. This
was recently highlighted particularly for maternal
mortality (2). Malawi is one of the countries where the
impact of the HIV epidemic is clearly visible on the
maternal mortality rate (MMR) (Fig. 1). Only after
the year 2000 it is possible to see some positive trend in
the MMR in Malawi, supposedly due to extensive HIV
testing and the provision of antiretroviral treatment.
Fyson Kasenga further describes the development of
the programme for prevention of mother-to-child trans-
mission (PMTCT) of HIV-1 at Malamulo Hospital, a
private not-for-profit missionary hospital in Malawi.
Several of the observations done in this setting are
actually generalisable to other antenatal care (ANC)
settings. The first observation is that PMTCT performs
much better after a couple of years when nurses and
midwives have learned how to correctly perform
PMTCT in a good manner. The second observation is
that after switching from voluntary counselling and
testing (VCT) to routine counselling and testing
(RCT), the programme soon becomes much more
acceptable to the community and even to the health
workers themselves. With the introduction of RCT, all
the issues surrounding HIV have become less stigmatis-
ing within the health institution and health workers,
generally, are able to treat HIV as an ordinary disease
like tuberculosis without stigmatising the clients. A
growing number of reports from a variety of countries
are describing the same positive shift after moving to
RCT in ANC. In Scandinavia, routine testing was
introduced as soon as there were reliable tests, i.e. in
Sweden as early as in 1987, more than 20 years ago!
The third observation is that in Malamulo, the
government’s initiative to provide free maternal care
largely facilitated the task of carrying out PMTCT. It
seems an inevitable conclusion that part of the effort to
prevent HIV infections in low-income settings is to invest
more resources in health care, particularly reproductive
health care.
In December 2009, WHO launched new guidelines
for PMTCT and for infant feeding in the context of
HIV (3, 4). The new guidelines propose that all HIV-
positive mothers should receive antiretroviral treatment
or prophylaxis during pregnancy, delivery and breast-
feeding. If the immune status of the mother is weakened
(with a CD4 count below 350), then she should receive
lifelong highly active antiretroviral treatment (HAART)
for her own health. This treatment should be started
immediately and this will also protect the child from
HIV-infection. If the mother does not need HAART for
her own health (CD4 count above 350), she should
receive antiretroviral prophylaxis, which should be
initiated as early as 14 weeks’ gestation. A new guiding
principle is that the prophylaxis should continue in some
form until 1 week after all exposure to breast milk has
ended. WHO are suggesting two alternatives, option A
and B. Option A, antiretroviral prophylaxis, consists of:
(a) daily zidovudine (AZT) during pregnancy, single
dose nevirapine (NVP) at onset of labour, AZT
lamivudine (3TC) during labour, delivery and for 7
days after delivery. In breastfeeding infants, maternal
ARV prophylaxis should be coupled with daily admin-
istration of NVP to the infant from birth until 1 week
after all exposure to breast milk has ended. Option B,
antiretroviral prophylaxis, consists of three ARV drugs
and there are several recommended regimens: AZT
3TC with either lopinavir (LPV/r) or abacavir (ABC)
or efavirenz (EFV). The last alternative recommended
drug combination is tenofovir (TDF), emtricitabine
(FTC)EFV. With option B, the infant only needs
daily nevirapine for 6 weeks.
The new WHO guidelines for infant feeding states that,
‘Mothers known to be HIV-infected (and whose infants
are HIV uninfected or of unknown HIV status) should
exclusively breastfeed their infants for the first 6 months
of life, introducing appropriate complementary foods
thereafter, and continue breastfeeding for the first 12
months of life’. This means that the health staff can now
advice the mothers to breastfeed their infants as the daily
nevirapine prophylaxis given to the baby will protect the
infant from HIV infection.
These new WHO recommendations are based on
recently published studies indicating that it is possible
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is not necessary to avoid breastfeeding in order to protect
the child. This is good news as we do not need to advise
mothers to avoid breastfeeding. But it puts a high burden
on the health system: the health system should now trace
the HIV-positive mothers early in pregnancy, provide
them with good advice and drugs throughout the
pregnancy, the mothers need to give birth in a clinic in
order to get the drugs needed and they need to be
followed closely throughout the breastfeeding period. Is
this at all feasible in places like Malamulo? I would tend
to say ‘no, not with the current resources’. Here again,
reports from the real life, such as the paper by Fyson
Kasenga, are important to inform us. It sends a strong
message that the new guidelines need to be followed by
more resources for ANC, delivery care and postnatal
follow-up.
Another important message from the work by Fyson
Kasenga  however, indirect  is that preventing HIV
transmission from mother-to-child does not prevent the
spread of HIV in the community. This can be illustrated
by two photographs from a recent campaign in Uganda
(Fig. 2a, b). The spread of HIV happens among
adolescents and adults, and PMTCT does nothing to
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Fig. 1. Maternal mortality in Malawi from 1980 to date. From page 171 in the web appendix (1).
Fig. 2. Two posters from Uganda: (a) November 2009 and (b) January 2010, highlighting the fact that HIV spreads in sexual
networks.
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to the recent oil leak in the Mexico Gulf: the leaking
pipe is releasing millions of litres of crude oil, which
ultimately destroys the shores and the wildlife around
the Gulf. PMTCT is like trying to stop the oil
reaching the shores, but not trying to prevent the
leakage at the source. In a long-term perspective, it
will be important to include reproductive health care,
such as ANC and delivery care, in primary prevention
efforts in order to avoid mothers being HIV-infected in
the first place. This will again require more resources
and it will require innovative methods to involve the
male partners, as pointed out by Fyson Kasenga, and
it will also require that we provide good advice to the
HIV-negative mothers in the antenatal clinic. Com-
monly today the HIV-negative mothers are congratu-
lated on their results, but we do not provide advise on
how to remain HIV-negative. And how many years
will we have to wait before we have enough midwives
so that they are able to participate in the primary
prevention of HIV, i.e. giving information in the
primary and secondary schools in their area?
So, in order to make it happen at the next level, there is
a need to mobilise funds for the health system and for
primary prevention of HIV!
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